A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is
Insilico Adme Profiling Of Cdk9 Inhibitors
Several drug targets have been identified in fighting against cancer. Inhibition of Cell cycle is one of the strategies used in anti-cancer research. CDKs [Cyclin Dependent Kinases] were found to be one of the promising drug targets. This work aims to find a potential molecule to inhibit CDKs that are involved in cell cycle progression. CDK 9 was chosen as potential drug target for cancer. Virtual screening was carried out against CDK 9 protein using Molecular Docking tools with molecules fromdoi:10.5281/zenodo.1207094 fatcat:ijv7s5mjhfdrlhbvjdfnenbscq